Does hope match the hype for targeted drugs?
Brown
Hannah
H
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D015195:Drug Design; D000077156:Gefitinib; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D011799:Quinazolines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib